FDA approval of tirzepatide for OSA sparks a surge in referrals as experts highlight weight loss benefits, symptom relief, and patient selection.
Vaishnavi Kundel, MD
Advertisement
Vaishnavi Kundel, MD: Sleep medicine and pulmonary medicine specialist at Mount Sinai.
Articles by Vaishnavi Kundel, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
Omalizumab-Facilitated OIT Enables Maintenance Dosing in Food Allergy
2
VESALIUS-CV: Evolocumab Prevents Cardiovascular Disease in High-Risk Diabetes
3
Socrodeucitinib Meets Primary Endpoint in Phase 2 Psoriasis Study
4
New Liver Cancer BEACON-HCC Framework Shows 96.6% Concordance in Pilot
5